La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Receptors, Dopamine (drug effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Receptors, Dopamine (classification) < Receptors, Dopamine (drug effects) < Receptors, Dopamine (genetics)  Facettes :

List of bibliographic references indexed by Receptors, Dopamine (drug effects)

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000A70 (2014) Amaal Al Dakheel [Canada] ; Isabelle Beaulieu-Boire ; Susan H. FoxEmerging drugs for levodopa-induced dyskinesia.
001473 (2012) Alain Dagher [Canada]ADDICTION AS ABERRANT LEARNING—EVIDENCE FROM PARKINSON'S DISEASE
002903 (2006) Pepijn Van Den Munckhof [Canada] ; Francois Gilbert [Canada] ; Michel Chamberland [Canada] ; Daniel Levesque [Canada] ; Jacques Drouin [Canada]Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of parkinson's disease
002953 (2005) Wonsuk Yang [États-Unis] ; Evelyn Tiffany-CastiglioniThe bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis.
002D86 (2003) A Jon Stoessl [Canada] ; Raúl De La Fuente-FernándezDopamine receptors in Parkinson's disease: imaging studies.
002F18 (2003) A. Hadj Tahar [Canada] ; R. Grondin [Canada] ; L. Gregoire [Canada] ; F. Calon [Canada] ; T. Di Paolo [Canada] ; P. J. Bedard [Canada]New insights in Parkinson's disease therapy: Can levodopa-induced dyskinesia ever be manageable
003622 (1999) D B Calne [Canada]Differentiation of dopamine agonists and their role in the treatment of Parkinson's disease.
003848 (1998) E R Marcotte [Canada] ; A. Chugh ; R K Mishra ; R L JohnsonProtection against MPTP treatment by an analog of Pro-Leu-Gly-NH2 (PLG, MIF-1)
003F10 (1995) P. Seeman [Canada]Therapeutic receptor-blocking concentrations of neuroleptics.
004315 (1993) P. Seeman [Canada] ; H H Van TolDopamine receptor pharmacology.
004433 (1993) A. Parent [Canada] ; B. LavoieThe heterogeneity of the mesostriatal dopaminergic system as revealed in normal and Parkinsonian monkeys
004453 (1993) B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. BedardEffect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors
004457 (1993) H. Takahashi [Canada] ; B. J. Snow [Canada] ; T. G. Nygaard ; D. B. Calne [Canada]Clinical heterogeneity of dopa-responsive dystonia : PET observations
004526 (1992) Baltazar Gomez-Mancilla [Canada] ; Paul J. Bédard [Canada]Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys
004528 (1992) H. A. Robertson [Canada]Dopamine receptor interactions: some implications for the treatment of Parkinson's disease
004629 (1992) H. A. Robertson [Canada]Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson's disease : sites of action and implications for the pathogenesis of dyskinesias
004841 (1990) A. Parent [Canada] ; B. Lavoie ; Y. Smith ; P. BédardThe dopaminergic nigropallidal projection in primates: distinct cellular origin and relative sparing in MPTP-treated monkeys.
004860 (1990) M N Hassan [Canada] ; J H Thakar ; J D GrimesBehavioral and biochemical effects of 4-phenylpyridine, 2-phenylpyridine, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rodents.
004897 (1990) C. Rouillard [Canada] ; P. J. Bédard [Canada] ; T. Di Paolo [Canada]Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393
004B89 (1988) Mohamed N. Hassan [Canada] ; Jay H. Thakar [Canada]Dopamine receptors in Parkinson's disease
004C64 (1988) E. C. Wolters ; J. C. Kebabian ; M. Guttman ; E. Mak ; B. D. Pate ; D. B. CalneA new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeys

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Receptors, Dopamine (drug effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Receptors, Dopamine (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Receptors, Dopamine (drug effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022